A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder-Reference-Cited by-同舟云学术

A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder

Published:2021-08 Issue:4 Volume:19 Page:325-332
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Challapalli Amarnath^ORCID,Masson Susan,White Paul^ORCID,Dailami Narges,Pearson Sylvia,Rowe Edward,Koupparis Anthony^ORCID,Oxley Jon,Abdelaziz Ahmed^ORCID,Ash-Miles Janice^ORCID,Bravo Alicia,Foulstone Emily,Perks Claire^ORCID,Holly Jeff^ORCID,Persad Raj,Bahl Amit^ORCID

Funder

Sanofi Genzyme

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference48 articles.

1. Office for National Statistics. Cancer Statistics registrations: registrations of cancer diagnosed in 2017. 2019 [cited 2021 9th Mar] https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2017.

2. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis;Lancet,2003

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Eur Urol,2005

4. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer;Calabro;Eur Urol,2009

5. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis;Winquist;J Urol,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study;Medical Oncology;2024-08-06

2. Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization;npj Precision Oncology;2024-05-18

3. The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-08

4. Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review;Frontiers in Oncology;2021-08-05

5. Programmed cell death, redox imbalance, and cancer therapeutics;Apoptosis;2021-07-08